Guntram Schernthaner
Department of Medicine I
Rudolfstiftung Hospital
Vienna
Austria
Name/email consistency: high
- Cardiovascular risk and thiazolidinediones--what do meta-analyses really tell us? Schernthaner, G., Chilton, R.J. Diabetes. Obes. Metab (2010)
- Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR. Schernthaner, G. Wien. Med. Wochenschr (2010)
- Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetes. Schernthaner, G., Guerci, B., Gallwitz, B., Rose, L., Nicolay, C., Kraus, P., Kazda, C. Diabetes Metab. (2010)
- Pleiotropic effects of thiazolidinediones on traditional and non-traditional atherosclerotic risk factors. Schernthaner, G. Int. J. Clin. Pract. (2009)
- Bariatric surgery in patients with morbid obesity and type 2 diabetes. Schernthaner, G., Morton, J.M. Diabetes. Care (2008)
- Kidney disease in diabetology. Schernthaner, G. Nephrol. Dial. Transplant. (2007)
- Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity. Schernthaner, G.H., Kopp, H.P., Kriwanek, S., Krzyzanowska, K., Satler, M., Koppensteiner, R., Schernthaner, G. Obes. Surg (2006)
- Is dyslipidaemia important if we control glycaemia?. Schernthaner, G. Atheroscler. Suppl (2005)
- GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Schernthaner, G., Grimaldi, A., Di Mario, U., Drzewoski, J., Kempler, P., Kvapil, M., Novials, A., Rottiers, R., Rutten, G.E., Shaw, K.M. Eur. J. Clin. Invest. (2004)
- Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial. Schernthaner, G., Matthews, D.R., Charbonnel, B., Hanefeld, M., Brunetti, P. J. Clin. Endocrinol. Metab. (2004)